Sodium orthovanadate
ALDRICH/450243 - 99.98% trace metals basis
Synonym: Trisodium vanadate
CAS Number: 13721-39-6
Empirical Formula (Hill Notation): Na3O4V
Molecular Weight: 183.91
EC Number: 237-287-9
MDL Number: MFCD00003511
Linear Formula: Na3VO4
Product Type: Chemical
| assay | 99.98% trace metals basis |
| form | solid |
| InChI | 1S/3Na.4O.V/q3*+1;;3*-1; |
| InChI key | IHIXIJGXTJIKRB-UHFFFAOYSA |
| mp | 850-866 °C (lit.) |
| Quality Level | 200 ![]() |
| reaction suitability | core: vanadium |
| reagent type: catalyst | |
| SMILES string | [Na+].[Na+].[Na+].[O-][V] |
| Application: | Sodium orthovanadate (Na3VO4) can be used as a metal precursor in the synthesis of: • Vanadium-MCM-48 (V-MCM-48) by anion-exchange method. V-MCM-48 is used as a catalyst in oxidation of styrene to benzaldehyde. • Nanorods of vanadium oxide particles by glycothermal method. • Yttrium vanadate (YVO4) doped with colloidal europium. |
| Biochem/physiol Actions: | An inhibitor of protein tyrosine phosphatases, alkaline phosphatases and ATPases. |
| Biochem/physiol Actions: | Inhibits ATPase, alkaline phosphatase and tyrosine phosphatase. Decavanadate, which is formed at acidic pH, inhibits inositol 1,4,5-trisphosphate (IP3)-induced Ca2+ release from endocrine cells and blocks IP3 binding to its receptor in brain tissue. |
| Other Notes: | 2024 CiteAb Award Winner for Supplier Succeeding in Parkinson′s Research ![]() |
| Packaging: | 10, 50 g in poly bottle |
| Packaging: | Exhibits various biological and physiological effects in the human body |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P301 + P312 + P330 |
| Hazard Codes | Xn |
| Risk Statements | 20/21/22 |
| Safety Statements | 22-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | 99.98% trace metals basis |
| mp | 850-866 °C (lit.) |
| UNSPSC | 12161600 |


